Mwanzo068270 • KRX
add
Celltrion Inc
Bei iliyotangulia
₩ 171,200.00
Bei za siku
₩ 170,900.00 - ₩ 176,200.00
Bei za mwaka
₩ 144,615.31 - ₩ 188,800.00
Thamani ya kampuni katika soko
40.65T KRW
Wastani wa hisa zilizouzwa
elfu 464.12
Uwiano wa bei na mapato
71.31
Mgao wa faida
0.39%
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 961.46B | 9.91% |
Matumizi ya uendeshaji wa biashara | 301.28B | 2.01% |
Mapato halisi | 61.17B | -21.59% |
Kiwango cha faida halisi | 6.36 | -28.70% |
Mapato kwa kila hisa | 276.00 | -20.06% |
EBITDA | 319.79B | 56.22% |
Asilimia ya kodi ya mapato | -20.74% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 824.00B | -20.06% |
Jumla ya mali | 20.55T | 2.10% |
Jumla ya dhima | 3.89T | 24.20% |
Jumla ya hisa | 16.66T | — |
hisa zilizosalia | 220.28M | — |
Uwiano wa bei na thamani | 2.28 | — |
Faida inayotokana na mali | 2.93% | — |
Faida inayotokana mtaji | 3.14% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 61.17B | -21.59% |
Pesa kutokana na shughuli | 188.14B | -35.92% |
Pesa kutokana na uwekezaji | -115.46B | -211.15% |
Pesa kutokana na ufadhili | -196.36B | 20.36% |
Mabadiliko halisi ya pesa taslimu | -178.62B | -213.72% |
Mtiririko huru wa pesa | 92.77B | -9.21% |
Kuhusu
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2002
Tovuti
Wafanyakazi
2,680
